Capping out-of-pocket drug costs for Medicare patients wouldn't lower drug prices

Apr 30, 2018
Several health economists and policy experts argue until Washington forces drug companies to lower their overall prices, an out-of-pocket Medicare cap is just dabbling at the edges.
A pharmacy technician counts out a prescription of antibiotic pills.
Joe Raedle/Getty Images

Need some Econ 101?

Our new Marketplace Crash Course is here to help. Sign-up for free, learn at your own pace.